Please assess the completion status of the following clinical trial:

Trial Title: IBCSG Trial 22-00 Serum Substudy

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: OTHER
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Patient must be randomized to the core protocol. Written informed consent for the serum substudy must be signed and dated by the patient and investigator~* Patient must not have begun CM maintenance (if randomized to CM maintenance)~Exclusion Criteria:~* Patient not randomized to the core protocol~* Patient already begun CM maintenance (if randomized to CM maintenance)

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Induction chemotherapy (Type: ACTIVE_COMPARATOR): Approved induction CT regimen after randomization
- Induction chemotherapy followed by CM maintenance (Type: EXPERIMENTAL): Approved induction chemotherapy followed by 12 months of CM maintenance

Based on this trial design, predict the completion outcome and termination type (if applicable).